Filter list by keyword
Show More
Show Less
to
of
Total
Sorry, no data available.
IMPORTANT:
• The Fund's investments in equities could incur significant losses due to higher fluctuation of equity values. The Fund's investments are concentrated in companies associated with the Next Generation Health Care Theme. This may result in greater volatility than a more diverse portfolio of investments. The Fund’s investments in companies involved with new and emerging themes in health care may be affected by technological and economic, political or regulatory developments. This may involve increased risks such as financial risk on research and development, dependent risks on technologies that may rapidly fall into obsolescence, loss or impairment of intellectual property rights and/or licenses, and unpredictable changes in growth rates and competition.
• The Fund is subject to currency risk, foreign investments restrictions risk, emerging market risk, and small /mid cap companies’ volatility and liquidity risks.
• The Fund may use derivatives for hedging and for investment purposes. However, usage for investment purposes will not be extensive. The Fund may suffer losses from its derivatives usage.
• The value of the Fund can be volatile and can go down substantially within a short period of time. It is possible that a certain amount of your investment could be lost.
• Investors should not make investment decisions based on this document alone. Investors should refer to the Prospectus and Key Facts Statement for details including risk factors.
• The Fund's investments in equities could incur significant losses due to higher fluctuation of equity values. The Fund's investments are concentrated in companies associated with the Next Generation Health Care Theme. This may result in greater volatility than a more diverse portfolio of investments. The Fund’s investments in companies involved with new and emerging themes in health care may be affected by technological and economic, political or regulatory developments. This may involve increased risks such as financial risk on research and development, dependent risks on technologies that may rapidly fall into obsolescence, loss or impairment of intellectual property rights and/or licenses, and unpredictable changes in growth rates and competition.
• The Fund is subject to currency risk, foreign investments restrictions risk, emerging market risk, and small /mid cap companies’ volatility and liquidity risks.
• The Fund may use derivatives for hedging and for investment purposes. However, usage for investment purposes will not be extensive. The Fund may suffer losses from its derivatives usage.
• The value of the Fund can be volatile and can go down substantially within a short period of time. It is possible that a certain amount of your investment could be lost.
• Investors should not make investment decisions based on this document alone. Investors should refer to the Prospectus and Key Facts Statement for details including risk factors.
Overview
All currency hedged share classes of this fund use derivatives to hedge currency risk. The use of derivatives for a share class could pose a potential risk of contagion (also known as spill-over) to other share classes in the fund. The fund’s management company will ensure appropriate procedures are in place to minimise contagion risk to other share class. Using the drop down box directly below the name of the fund, you can view a list of all share classes in the fund – currency hedged share classes are indicated by the word “Hedged” in the name of the share class. In addition, a full list of all currency hedged share classes is available on request from the fund’s management company
Performance
Performance
Chart
Performance chart data not available for display.
-
Returns
During this period performance was achieved under circumstances that no longer apply
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Total Return (%) | -15.57 | 2.73 | 9.18 | ||
| Benchmark (%) | -13.01 | 18.06 | 25.33 |
Past performance is not a guide to future performance. Investors may not get back the full amount invested.
If the share class of the fund has been launched for less than 5 years, please refer to the fund factsheet for the performance information calculated from the launch date to the end of launch year.
Performance is calculated based on the calendar year end, NAV-to-NAV with dividend reinvested.
These figures show by how much the Share Class of the Fund increased or decreased in value during the calendar year being shown. Performance is calculated in the relevant Share Class currency, including ongoing charges and taxes and excluding subscription and redemption fees, if applicable.
Where no past performance is shown there was insufficient data available in that calendar year to provide performance.
Please refer to the Key Facts section on the right for the inception date of the Fund and the Share Class.
If the share class of the fund has been launched for less than 5 years, please refer to the fund factsheet for the performance information calculated from the launch date to the end of launch year.
Performance is calculated based on the calendar year end, NAV-to-NAV with dividend reinvested.
These figures show by how much the Share Class of the Fund increased or decreased in value during the calendar year being shown. Performance is calculated in the relevant Share Class currency, including ongoing charges and taxes and excluding subscription and redemption fees, if applicable.
Where no past performance is shown there was insufficient data available in that calendar year to provide performance.
Please refer to the Key Facts section on the right for the inception date of the Fund and the Share Class.
Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.
| 1y | 3y | 5y | 10y | Incept. | |
|---|---|---|---|---|---|
| Total Return (%) | 6.28 | 5.68 | - | - | 1.31 |
| Benchmark (%) | 7.58 | 14.00 | - | - | 9.61 |
| YTD | 1m | 3m | 6m | 1y | 3y | 5y | 10y | Incept. | |
|---|---|---|---|---|---|---|---|---|---|
| Total Return (%) | 9.26 | 7.55 | 18.49 | 25.10 | 6.28 | 18.03 | - | - | 5.78 |
| Benchmark (%) | 8.03 | -0.56 | 6.84 | 12.45 | 7.58 | 48.15 | - | - | 48.42 |
Past performance is not a guide to future performance. Investors may not get back the full amount invested.
Performance is calculated based on the period NAV-to-NAV with dividend reinvested. Performance figures are calculated net of fees.
These figures show by how much the Share Class of the Fund increased or decreased in value during the period being shown. Performance is calculated in the relevant share class currency, including ongoing charges and taxes and excluding subscription and redemption fees, if applicable.
Where no past performance is shown there was insufficient data available in that period to provide performance.
Please refer to the Key Facts section for the inception date of the Fund and the Share Class.
Performance is calculated based on the period NAV-to-NAV with dividend reinvested. Performance figures are calculated net of fees.
These figures show by how much the Share Class of the Fund increased or decreased in value during the period being shown. Performance is calculated in the relevant share class currency, including ongoing charges and taxes and excluding subscription and redemption fees, if applicable.
Where no past performance is shown there was insufficient data available in that period to provide performance.
Please refer to the Key Facts section for the inception date of the Fund and the Share Class.
The figures shown relate to past performance. Past performance is not a reliable indicator of future performance. Markets could develop very differently in the future. It can help you to assess how the fund has been managed in the past
Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock
Key Facts
Key Facts
Net Assets of Fund
as of 04-Dec-2025
USD 18,064,123
Fund Inception
07-Jun-2021
Fund Base Currency
USD
Benchmark
MSCI All Country World Net TR Index - in EUR (EUR)
Initial Charge
5.00%
ISIN
LU2372745807
Performance Fee
0.00%
Minimum Subsequent Investment
EUR 1000
Domicile
Luxembourg
Management Company
BlackRock (Luxembourg) S.A.
Dealing Settlement
Trade date + 3 days
Bloomberg Ticker
BNGHD2E
SFC-authorised ESG fund
No
Share Class Inception Date
11-Aug-2021
Share Class Currency
EUR
Asset Class
Equity
SFDR Classification
Other
Management Fee
0.68%
Management Fee (incl Distribution Fee, if any)
0.68%
Minimum Initial Investment
EUR 100000
Use of Income
Accumulating
Regulatory Structure
UCITS
Morningstar Category
Sector Equity Healthcare
Dealing Frequency
Daily, forward pricing basis
SEDOL
BMW7TR2
For Fee details, please refer to the Fund Prospectus.
Portfolio Characteristics
Portfolio Characteristics
Number of Holdings
as of 28-Nov-2025
125
P/E Ratio
as of 28-Nov-2025
30.54
Standard Deviation (3y)
as of 30-Nov-2025
15.58%
P/B Ratio
as of 28-Nov-2025
4.28
Ratings
Ratings
Holdings
Holdings
as of 28-Nov-2025
| Name | Weight (%) |
|---|---|
| MEDTRONIC PLC | 3.40 |
| JOHNSON & JOHNSON | 3.26 |
| ABBOTT LABORATORIES | 3.16 |
| ROCHE HOLDING PAR AG | 3.05 |
| EXACT SCIENCES CORP | 2.93 |
| Name | Weight (%) |
|---|---|
| EDWARDS LIFESCIENCES CORP | 2.64 |
| GUARDANT HEALTH INC | 2.63 |
| GILEAD SCIENCES INC | 2.36 |
| BIOGEN INC | 2.28 |
| IQVIA HOLDINGS INC | 2.23 |
The Fund is actively managed and its composition will vary. Holdings shown are for illustrative purposes only and should not be deemed as a recommendation to buy or sell the securities listed. Fund details, holdings and characteristics are as of the date noted and subject to change.
Holdings subject to change.
Exposure Breakdowns
Exposure Breakdowns
Allocations are subject to change. Source: BlackRock
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management. Allocations are subject to change.
Due to rounding, the total may not be equal to 100%
Due to rounding, the total may not be equal to 100%
Pricing & Exchange
Pricing & Exchange
| Share Class | Currency | NAV | NAV Amount Change | NAV % Change | NAV As Of | 52wk High | 52wk Low | ISIN |
|---|---|---|---|---|---|---|---|---|
| D2 | EUR | 8.79 | -0.02 | -0.23 | 04-Dec-2025 | 8.99 | 6.61 | LU2372745807 |
| D2 | USD | 10.26 | -0.01 | -0.10 | 04-Dec-2025 | 10.42 | 7.30 | LU2310090514 |
| A2 | EUR | 8.47 | -0.01 | -0.12 | 04-Dec-2025 | 8.66 | 6.40 | LU2310090944 |
| A2 | USD | 9.88 | -0.01 | -0.10 | 04-Dec-2025 | 10.04 | 7.07 | LU2310090431 |
| A2 Hedged | HKD | 94.05 | -0.12 | -0.13 | 04-Dec-2025 | 95.58 | 68.23 | LU2310091249 |
| A2 Hedged | SGD | 9.15 | -0.01 | -0.11 | 04-Dec-2025 | 9.30 | 6.67 | LU2310091165 |
Unless otherwise specified, all information as of the month end.
Portfolio Managers
Portfolio Managers
Erin Xie
Xiang Liu
ESG Integration
ESG Integration
BlackRock considers many investment risks in our processes. In order to seek the best risk-adjusted returns for our clients, we manage material risks and opportunities that could impact portfolios, including financially material Environmental, Social and/or Governance (ESG) data or information, where available. See our Firm Wide ESG Integration Statement for more information on this approach and fund documentation for how these material risks are considered within this product, where applicable.
